3.4.2 Subsequent Follow-up Evaluations The second follow-up evaluati on will take place 1 month (± 5 days ) after the first follow-up evaluation (Day 56). Subsequent f ollow-up evaluations will take place every 1-2 months for the first year, and then annually or a s clinically appropriate as de termined by the PI. As noted in Section 3.4.1, additional leukapheresis may be pe rformed only at the first fol low-up evaluation. It will not be performed at any ot her post-treatment evaluations.